References
- Holmstrom G, Larsson E. Outcome of retinopathy of prematurity. Clin Perinatol 2013;40:311–321.
- Bonamy AK, Holmstrom G, Stephansson O, et al. Preterm birth and later retinal detachment: A population-based cohort study of more than 3 million children and young adults. Ophthalmology 2013;120:2278–2285.
- Asano MK, Papakostas TD, Palma CV, et al. Visual outcomes of surgery for stage 4 and 5 retinopathy of prematurity. Int Ophthalmol 2014;54:225–237.
- Gunn DJ, Cartwright DW, Gole GA. Prevalence and outcomes of laser treatment of aggressive posterior retinopathy of prematurity. Clin Experiment Ophthalmol 2014;42(5):495--465.
- Distler JH, Hirth A, Kurowska-Stolarska M, et al. Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 2003;47:149–161.
- Hellstrom A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet 2013;382:1445–1457.
- Tombran-Tink J. PEDF in angiogenic eye diseases. Curr Mol Med 2010;10:267–278.
- Hartmann JS, Thompson H, Wang H, et al. Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity. Mol Vis 2010;17:1577–1587.
- Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994;35:101–111.
- Stellmach V, Crawford SE, Zhou W, et al. Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc Natl Acad Sci U S A 2001;98:2593–2597.
- Gehlbach P, Demetriades AM, Yamamoto S, et al. Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization. Gene Ther 2003;10(8):637--646.
- Mori K, Gehlbach P, Yamamoto S, et al. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci 2002;43:1994–2000.
- Apte RS, Barreiro RA, Duh E, et al. Stimulation of neovascularization by the anti-angiogenic factor PEDF. Invest Ophthalmol Vis Sci 2004;45:4491–4497.
- Haurigot V, Villacampa P, Ribera A, et al. Long-term retinal PEDF overexpression prevents neovascularization in a murine adult model of retinopathy. PloS One 2012;7:e41511.
- Broadhead ML, Dass CR, Choong PF. Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model. Br J Cancer2011; 105:1503–1511.
- Park S, DiMaio TA, Scheef EA, et al. PECAM-1 regulates proangiogenic properties of endothelial cells through modulation of cell-cell and cell-matrix interactions. Am J Cell Physiol 2010;299:C1468–1484.
- Tokunaga CC, Mitton KP, Dailey W, et al. Effect of Anti-VEGF Treatment on Developing Retina Following Oxygen-Induced Retinopathy. Invest Ophthalmol Vis Sci 2014;55:1884–1892.
- Shibuya M. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem 2013;153:13–19.
- Cavallaro G, Filippi L, Bagnoli P, et al. The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge. Acta Ophthalmol 2014;92:2–20.
- Sukhikh GT, Panova IG, Smirnova YA, et al. Expression of transforming growth factor-beta2in vitreous body and adjacent tissues during prenatal development of human eye. Bull Exp Biol Med 2010;150:117–1121.
- Moleirinho S, Guerrant W, Kissil JL. The Angiomotins - From discovery to function. FEBS Lett 2014;588(16):2693--2703.
- Aparicioa S, Sawanta S, Lara N, et al. Expression of angiogenesis factors in human umbilical vein endothelial cells and their regulation by PEDF. Biochem Biophys Res Commun 2005;326:387–94.
- Ren JG, Jie C, Talbot C. How PEDF prevents angiogenesis: a hypothesized pathyway. Med Hypotheses 2005;64:74–78.
- Sheikpranbabu S, Haribalaganesh R, Banumathi E, et al. Pigment epithelium-derived factor inhibits advanced glycation end-product-induced angiogenesis and stimulates apoptosis in retinal endothelial cells. Life Sci 2009;85:719–731.